ArticleOncotarget2017

Inhibition of Miro1 disturbs mitophagy and pancreatic β-cell function interfering insulin release via IRS-Akt-Foxo1 in diabetes.

Lingling Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.